Kestra Medical (KMTS) Director Raymond Cohen Receives RSU Award

What Happened
Raymond W. Cohen, a director of Kestra Medical Technologies, was granted 7,217 restricted stock units (RSUs) on September 9, 2026. The grant is reported as an award/acquisition (code A); no per-share price or immediate cash value is reported because RSUs convert to common shares upon vesting rather than representing an open-market purchase.

Key Details

• Transaction date: 2026-09-09; Form 4 filed 2026-09-10 (filed promptly).
• Shares/units granted: 7,217 RSUs. Price: N/A (RSUs; no cash paid).
• Shares owned after transaction: not disclosed on this filing.
• Footnote: Each RSU entitles the holder to one common share; the RSUs vest on September 9, 2027, contingent on Cohen’s continued service through that date.
• Transaction code: A (award/grant).

Context
RSUs are a form of equity compensation that do not convey tradable shares until they vest; they are a retention incentive rather than an immediate market purchase or sale. This grant does not by itself indicate Cohen is buying or selling stock; it indicates compensation aligned with future service through the 2027 vesting date.